What they were paid
Aurinia Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $17,251 | $0 | $0 | — | $17,251 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Aurinia Pharmaceuticals Inc. DEF 14A filed April 21, 2026, accession 0001600620-26-000039, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Aurinia Pharmaceuticals pays directors a $45,000 cash retainer and $200,000 in Options.
The rest of the Aurinia Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Craig Johnson | Lead Independent Director | $276,686 |
| Current Directors | Independent Director | — |
| Former Directors | Independent Director | — |
| Jeffrey Bailey | Independent Director | $274,873 |
| Kathy Goetz | Independent Director | $372,694 |
| Kevin Tang | Chair of the Board | $0 |
| Tina S. Nova, Ph.D | Independent Director | $374,157 |
The full Aurinia Pharmaceuticals compensation record
free company briefThis page is one director within Aurinia Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat